WEST PHARMACEUTICAL SERVICES, INC. financials

WST CIK 0000105770

Source: EDGAR filings · raw companyfacts JSON · Built 2026-04-25T10:22:06Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 468.90M 276.40M 414.50M 439.40M 330.60M 298.10M
EBITDA 756.30M 725.30M 813.30M 854.60M 874.60M 516.00M
Working Capital 1.32B 987.70M 1.26B 1.40B 1.15B 870.30M
Net Debt -465.10M -179.30M -544.90M -576.40M -437.30M -289.80M
Gross Margin 35.91% 34.51% 38.28% 39.36% 41.52% 35.76%
Operating Margin 19.03% 19.70% 22.92% 25.43% 26.57% 18.95%
Net Margin 16.06% 17.03% 20.12% 20.30% 23.37% 16.13%
Return on Equity (ROE) 15.54% 18.37% 20.60% 21.82% 28.34% 18.67%
Return on Assets (ROA) 11.56% 13.52% 15.50% 16.20% 19.97% 12.39%
Current Ratio 3.0206 2.7945 2.8824 3.6985 2.9322 2.7288
Debt-to-Equity 0.1027 0.1138 0.1073 0.1184 0.1393 0.1756
Effective Tax Rate 20.24% 18.36% 17.52% 16.87% 14.31% 18.07%
Cash Conversion Ratio 1.5289 1.3262 1.3086 1.2357 0.8824 1.3648
Accruals Ratio -0.0611 -0.0441 -0.0478 -0.0382 0.0235 -0.0452
SBC % of Revenue 0.77% 0.65% 0.79% 0.82% 1.32% 1.58%
CapEx Coverage 2.6401 1.7332 2.145 2.5439 2.3047 2.7093
Free Cash Flow Per Share $6.45 $3.75 $5.50 $5.80 $4.33 $3.93

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 40.5214 48.9626 44.6853 30.4463 54.0957 61.9934
P/FCF 42.6587 87.3423 63.9683 40.6 108.2439 72.0396
FCF Yield 2.34% 1.14% 1.56% 2.46% 0.92% 1.39%
EV / EBITDA 25.5784 32.4049 31.152 19.7321 39.2902 40.0681
P/S 6.4442 8.1856 8.7738 6.0409 12.2901 9.7652
P/B 6.2374 8.8292 8.9833 6.4954 14.9013 11.3049

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 3.07B 2.89B 2.95B 2.89B 2.83B 2.15B
Revenues 2.89B 2.83B 2.15B
Cost of Goods and Services Sold 1.97B 1.89B 1.82B 1.75B 1.66B 1.38B
Gross Profit 1.10B 998.50M 1.13B 1.14B 1.18B 767.80M
Research and Development Expense 74.30M 69.10M 68.40M 58.50M 52.80M 46.90M
Selling, General and Administrative Expense 393.60M 338.50M 353.40M 316.90M 362.80M 302.00M
Operating Income (Loss) 584.90M 569.90M 676.00M 734.00M 752.30M 406.90M
Income Tax Expense (Benefit) 121.60M 107.50M 122.30M 114.70M 107.20M 72.50M
Net Income (Loss) Attributable to Parent 493.70M 492.70M 593.40M 585.90M 661.80M 346.20M
Earnings Per Share, Basic $6.83 $6.75 $7.98 $7.87 $8.89 $4.68
Weighted Average Number of Shares Outstanding, Basic 72.30M 73.00M 74.30M 74.40M 74.40M 73.90M
Earnings Per Share, Diluted $6.79 $6.69 $7.88 $7.73 $8.67 $4.57
Weighted Average Number of Shares Outstanding, Diluted 72.70M 73.70M 75.30M 75.80M 76.30M 75.80M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 791.30M 484.60M 853.90M 894.30M 762.60M 615.50M
Assets, Current 1.98B 1.54B 1.94B 1.92B 1.74B 1.37B
Assets 4.27B 3.64B 3.83B 3.62B 3.31B 2.79B
Long-term Debt 202.80M 202.60M 206.80M 208.90M 253.00M 255.20M
Liabilities, Current 654.90M 550.40M 671.80M 519.00M 594.10M 503.40M
Long-term Debt, Excluding Current Maturities 202.80M 202.60M 72.80M 206.70M 208.80M 252.90M
Liabilities 1.09B 961.10M 948.50M 931.90M 978.40M 939.30M
Stockholders' Equity Attributable to Parent 3.18B 2.68B 2.88B 2.68B 2.34B 1.85B
Common Stock, Shares, Outstanding 72.00M 72.30M 73.50M 74.10M 74.20M 74.00M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 754.80M 653.40M 776.50M 724.00M 584.00M 472.50M
Payments to Acquire Property, Plant, and Equipment 285.90M 377.00M 362.00M 284.60M 253.40M 174.40M
Net Cash Provided by (Used in) Investing Activities -285.90M -378.70M -368.70M -288.20M -253.10M -179.50M
Payments for Repurchase of Common Stock 134.00M 560.90M 438.30M 202.80M 137.10M 115.50M
Net Cash Provided by (Used in) Financing Activities -185.10M -622.60M -459.60M -293.60M -168.10M -137.10M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Income Statement

26 concepts 3 units
Unit US$ · 20 concepts
Label Value Period
Other Operating Income (Expense), Net 0 2026-01-01 → 2026-03-31
Revenue from Contract with Customer, Excluding Assessed Tax 844.90M 2026-01-01 → 2026-03-31
Cost of Goods and Services Sold 548.50M 2026-01-01 → 2026-03-31
Gross Profit 296.40M 2026-01-01 → 2026-03-31
Research and Development Expense 15.80M 2026-01-01 → 2026-03-31
Finance Lease, Right-of-Use Asset, Amortization 500.00K 2026-01-01 → 2026-03-31
Asset Impairment Charges 300.00K 2026-01-01 → 2026-03-31
Selling, General and Administrative Expense 99.50M 2026-01-01 → 2026-03-31
Operating Income (Loss) 177.10M 2026-01-01 → 2026-03-31
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 1.90M 2026-01-01 → 2026-03-31
Investment Income, Net 5.10M 2026-01-01 → 2026-03-31
Foreign Currency Transaction Gain (Loss), before Tax -1.10M 2026-01-01 → 2026-03-31
Other Nonoperating Income (Expense) -200.00K 2026-01-01 → 2026-03-31
Finance Lease, Interest Expense 100.00K 2026-01-01 → 2026-03-31
InterestExpenseNonoperating 1.90M 2026-01-01 → 2026-03-31
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 180.10M 2026-01-01 → 2026-03-31
Income (Loss) from Equity Method Investments 3.40M 2026-01-01 → 2026-03-31
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 180.10M 2026-01-01 → 2026-03-31
Income Tax Expense (Benefit) 44.70M 2026-01-01 → 2026-03-31
Net Income (Loss) Attributable to Parent 138.80M 2026-01-01 → 2026-03-31
Unit shares · 3 concepts
Unit US$ / share · 3 concepts
Label Value Period
Earnings Per Share, Basic $1.93 2026-01-01 → 2026-03-31
Earnings Per Share, Diluted $1.92 2026-01-01 → 2026-03-31
Common Stock, Dividends, Per Share, Declared $0.22 2026-01-01 → 2026-03-31

Comprehensive Income

14 concepts 1 unit
Unit US$ · 14 concepts
Label Value Period
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax 400.00K 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax 0 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax -1.10M 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax -700.00K 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent -19.50M 2026-01-01 → 2026-03-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 100.00K 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent -100.00K 2026-01-01 → 2026-03-31
OciEquityMethodInvestmentAfterTaxParent 0 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent -19.70M 2026-01-01 → 2026-03-31
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 119.10M 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent 100.00K 2026-01-01 → 2026-03-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent 0 2026-01-01 → 2026-03-31
Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax, Parent 100.00K 2026-01-01 → 2026-03-31
OciEquityMethodInvestmentTaxParent 0 2026-01-01 → 2026-03-31

Balance Sheet

54 concepts 3 units
Unit US$ · 46 concepts
Label Value Period
Cash and Cash Equivalents, at Carrying Value 521.40M as of 2026-03-31
Accounts Receivable, after Allowance for Credit Loss, Current 685.60M as of 2026-03-31
Inventory, Net 452.60M as of 2026-03-31
Other Assets, Current 167.20M as of 2026-03-31
Assets, Current 1.83B as of 2026-03-31
Operating Lease, Right-of-Use Asset 110.20M as of 2026-03-31
Finance Lease, Right-of-Use Asset, after Accumulated Amortization 34.00M as of 2026-03-31
Property, Plant and Equipment, Gross 3.22B as of 2026-03-31
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 1.52B as of 2026-03-31
Property, Plant and Equipment, Net 1.70B as of 2026-03-31
Contract with Customer, Asset, after Allowance for Credit Loss 15.40M as of 2026-03-31
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures 209.20M as of 2026-03-31
Goodwill 109.20M as of 2026-03-31
Intangible Assets, Net (Excluding Goodwill) 7.00M as of 2026-03-31
Other Assets, Noncurrent 81.30M as of 2026-03-31
Unamortized Debt Issuance Expense 200.00K as of 2026-03-31
Contract with Customer, Liability 62.20M as of 2026-03-31
Deferred Income Tax Assets, Net 63.90M as of 2026-03-31
Operating Lease, Liability 113.40M as of 2026-03-31
Assets 4.11B as of 2026-03-31
Accounts Payable, Current 252.30M as of 2026-03-31
Accrued Income Taxes, Current 78.90M as of 2026-03-31
Accrued Liabilities, Current 46.60M as of 2026-03-31
Long-term Debt 202.80M as of 2026-03-31
Finance Lease, Liability 4.80M as of 2026-03-31
Business Combination, Contingent Consideration, Liability 3.00M as of 2026-03-31
Long-term Debt, Current Maturities 0 as of 2026-03-31
Finance Lease, Liability, Current 1.50M as of 2026-03-31
Other Liabilities, Current 202.20M as of 2026-03-31
Liabilities, Current 674.00M as of 2026-03-31
Long-term Debt, Excluding Current Maturities 202.80M as of 2026-03-31
Finance Lease, Liability, Noncurrent 3.30M as of 2026-03-31
Deferred Compensation Liability, Classified, Noncurrent 11.80M as of 2026-03-31
Liability, Defined Benefit Plan, Noncurrent 28.50M as of 2026-03-31
Deferred Income Tax Liabilities, Net 22.70M as of 2026-03-31
Other Liabilities, Noncurrent 87.60M as of 2026-03-31
Operating Lease, Liability, Noncurrent 92.00M as of 2026-03-31
Liabilities 1.12B as of 2026-03-31
Preferred Stock, Value, Issued 0 as of 2026-03-31
Common Stock, Value, Issued 18.80M as of 2026-03-31
Additional Paid in Capital 0 as of 2026-03-31
Treasury Stock, Common, Value 1.38B as of 2026-03-31
Accumulated Other Comprehensive Income (Loss), Net of Tax -125.20M as of 2026-03-31
Retained Earnings (Accumulated Deficit) 4.48B as of 2026-03-31
Stockholders' Equity Attributable to Parent 2.99B as of 2026-03-31
Liabilities and Equity 4.11B as of 2026-03-31
Unit shares · 7 concepts
Label Value Period
Preferred Stock, Shares Authorized 3.00M as of 2026-03-31
Preferred Stock, Shares Issued 0 as of 2026-03-31
Preferred Stock, Shares Outstanding 0 as of 2026-03-31
Common Stock, Shares Authorized 200.00M as of 2026-03-31
Common Stock, Shares, Issued 75.30M as of 2026-03-31
Common Stock, Shares, Outstanding 70.90M as of 2026-03-31
Treasury Stock, Common, Shares 4.40M as of 2026-03-31
Unit US$ / share · 1 concept
Label Value Period
Common Stock, Par or Stated Value Per Share $0.25 as of 2026-03-31

Cash Flow Statement

25 concepts 1 unit
Unit US$ · 25 concepts
Label Value Period
Depreciation 44.60M 2026-01-01 → 2026-03-31
Amortization 600.00K 2026-01-01 → 2026-03-31
Depreciation, Depletion and Amortization 45.20M 2026-01-01 → 2026-03-31
Share-based Payment Arrangement, Noncash Expense 6.60M 2026-01-01 → 2026-03-31
Finance Lease, Interest Payment on Liability 100.00K 2026-01-01 → 2026-03-31
Operating Lease, Payments 6.40M 2026-01-01 → 2026-03-31
Other Noncash Income (Expense) -1.00M 2026-01-01 → 2026-03-31
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 3.00M 2026-01-01 → 2026-03-31
Increase (Decrease) in Contract with Customer, Asset 3.50M 2026-01-01 → 2026-03-31
Capital Expenditures Incurred but Not yet Paid 26.10M 2026-01-01 → 2026-03-31
Increase (Decrease) in Contract with Customer, Liability 8.50M 2026-01-01 → 2026-03-31
Increase (Decrease) in Operating Capital 102.90M 2026-01-01 → 2026-03-31
Net Cash Provided by (Used in) Operating Activities 89.90M 2026-01-01 → 2026-03-31
Payments to Acquire Property, Plant, and Equipment 42.70M 2026-01-01 → 2026-03-31
Net Cash Provided by (Used in) Investing Activities -42.70M 2026-01-01 → 2026-03-31
Finance Lease, Principal Payments 300.00K 2026-01-01 → 2026-03-31
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 2.00M 2026-01-01 → 2026-03-31
Proceeds from Stock Options Exercised 5.50M 2026-01-01 → 2026-03-31
Payments for Repurchase of Common Stock 297.60M 2026-01-01 → 2026-03-31
Payments of Ordinary Dividends, Common Stock 15.80M 2026-01-01 → 2026-03-31
Payment, Tax Withholding, Share-based Payment Arrangement 2.50M 2026-01-01 → 2026-03-31
Net Cash Provided by (Used in) Financing Activities -308.70M 2026-01-01 → 2026-03-31
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents -8.40M 2026-01-01 → 2026-03-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -269.90M 2026-01-01 → 2026-03-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 521.40M as of 2026-03-31

Notes

58 concepts 5 units
Unit US$ · 45 concepts
Label Value Period
Operating Lease, Liability, Current 21.40M as of 2026-03-31
Foreign Currency Contract, Asset, Fair Value Disclosure 500.00K as of 2026-03-31
Share-based Payment Arrangement, Expense 6.60M 2026-01-01 → 2026-03-31
Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent 8.80M as of 2026-03-31
Related Party Transaction, Purchases from Related Party 34.00M 2026-01-01 → 2026-03-31
Debt Instrument, Fair Value Disclosure 202.20M as of 2026-03-31
Deferred Compensation Plan Assets 8.70M as of 2026-03-31
Foreign Currency Contracts, Liability, Fair Value Disclosure 4.80M as of 2026-03-31
Restructuring and Related Cost, Incurred Cost 1.80M 2026-01-01 → 2026-03-31
Inventory, Finished Goods, Net of Reserves 171.40M as of 2026-03-31
Inventory, Work in Process, Net of Reserves 108.70M as of 2026-03-31
Inventory, Raw Materials, Net of Reserves 172.50M as of 2026-03-31
Contract with Customer, Liability, Revenue Recognized 23.10M 2026-01-01 → 2026-03-31
Restructuring Reserve, Settled without Cash 900.00K 2026-01-01 → 2026-03-31
SegmentExpenditureAdditionToLongLivedAssets 42.70M 2026-01-01 → 2026-03-31
Dividends, Common Stock, Cash 15.90M 2026-01-01 → 2026-03-31
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12.00M 2026-01-01 → 2026-03-31
Treasury Stock, Value, Acquired, Cost Method 297.60M 2026-01-01 → 2026-03-31
Operating Lease, Cost 7.20M 2026-01-01 → 2026-03-31
Short-term Lease, Cost 900.00K 2026-01-01 → 2026-03-31
Variable Lease, Cost 2.50M 2026-01-01 → 2026-03-31
Lease, Cost 11.20M 2026-01-01 → 2026-03-31
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 200.00K 2026-01-01 → 2026-03-31
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 0 2026-01-01 → 2026-03-31
Finance Lease, Liability, to be Paid, Year One 1.50M as of 2026-03-31
Finance Lease, Liability, to be Paid, Year Two 1.10M as of 2026-03-31
Finance Lease, Liability, to be Paid, Year Three 600.00K as of 2026-03-31
Finance Lease, Liability, to be Paid, Year Four 400.00K as of 2026-03-31
Finance Lease, Liability, Payment, Due 5.20M as of 2026-03-31
Finance Lease, Liability, to be Paid, Remainder of Fiscal Year 1.10M as of 2026-03-31
Finance Lease, Liability, Undiscounted Excess Amount 400.00K as of 2026-03-31
Lessee, Operating Lease, Liability, to be Paid, Year One 21.10M as of 2026-03-31
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.20M as of 2026-03-31
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.00M as of 2026-03-31
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.40M as of 2026-03-31
Lessee, Operating Lease, Liability, to be Paid 140.30M as of 2026-03-31
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 21.00M as of 2026-03-31
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 26.90M as of 2026-03-31
Long-term Debt, Gross 203.00M as of 2026-03-31
Assets, Fair Value Disclosure 217.10M as of 2026-03-31
Financial and Nonfinancial Liabilities, Fair Value Disclosure 16.60M as of 2026-03-31
Gain (Loss) on Fair Value Hedges Recognized in Earnings 1.20M 2026-01-01 → 2026-03-31
OCI, before Reclassifications, Net of Tax, Attributable to Parent -20.20M 2026-01-01 → 2026-03-31
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent -500.00K 2026-01-01 → 2026-03-31
Unrecognized Tax Benefits 64.70M as of 2026-03-31
Unit segment · 1 concept
Label Value Period
Number of Reportable Segments 2 2026-01-01 → 2026-03-31

Other

2 concepts 2 units
Unit US$ · 1 concept
Label Value Period
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture 8.80M 2026-01-01 → 2026-03-31
Unit shares · 1 concept

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (WST CIK 0000105770), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.